Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New imaging agent could sharpen detection of recurrent brain tumors

NCT ID NCT04044937

First seen Mar 12, 2026 · Last updated Jun 02, 2026 · Updated 13 times

Summary

This study tested a special dye called fluoroethyltyrosine (FET) used during a PET scan to see if it can better detect brain tumors that have come back. Researchers enrolled 143 people with different types of brain tumors. The goal was to see how accurate the FET PET scan is at finding recurrent tumors compared to standard methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94115, United States

Conditions

The condition(s) this trial relates to.

brain cancer glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.